Request a Quotation

Your Contact Information
Peptides Logo
Support and counselling under:
+49(0)3302 - 2022000 info@peptides.de
€0.00*




MAGE 212-220 (HLA-C*07:01)
( EGDCAPEEK )



This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Sequence:EGDCAPEEK
Gene:MAGE
Delivery:3 weeks
C-Terminus:OH
N-Terminus:H
Amount:1 mg
Counter Ion:TFA
Protein:Melanoma-associated antigen
Species:Human
Allele:HLA-C*07:01
Application :T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :Cancer
Purity :95% HPLC-MS
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€105.00*

Prices excl. VAT plus shipping costs

Available, delivery time: 3-4 weeks


sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Amount in mg
Product number: EP07901_1

More MAGE peptides
HRSVA (Major surface glycoprotein G) Peptide Pool
Pool of 72 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Major surface glycoprotein G (UniProt ID: P03423) of Human respiratory syncytial virus A (strain A2) for T cell assays One unit allows the stimulation of 2,5 x 108 cells.

€316.40*
MAGE - A2 mutant (157-166) 161I ( YLQLIFGIEV )
#

From €105.00*
Details
MAGE 212-220 (HLA-C*07:01) ( EGDCAPEEK )
This Peptide MAGE HLA-C*07:01 (EGDCAPEEK) is for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
Details
MAGE-A1 161-169 (HLA-A*01:01) ( EADPTGHSY )
EADPTGHSY is a linear peptidic epitope (epitope ID11010) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
MAGE-A1 278-286 (HLA-A*02:01) ( KVLEYVIKV )
KVLEYVIKV is a linear peptidic epitope (epitope ID34095) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays

From €105.00*
Details
MAGE-A1 289-298 (HLA-B*07:02) ( RVRFFFPSL )
RVRFFFPSL is a linear peptidic epitope (epitope ID179897) studied as part of Melanoma-associated antigen 1 from Homo sapiens (human), tested in MHC ligand assays

From €105.00*
Details
MAGE-A1-3/A5 Mouse Kb/Db ( LGITYDGM )
LGITYDGM is a linear peptidic epitope studied as part of MageA2 protein from Mus musculus (mouse), tested in T cell assays and MHC ligand assay.

From €105.00*
Details
MAGE-A2 156-164 (HLA-A*24:02) ( EYLQLVFGI )
EYLQLVFGI is a linear peptidic epitope (epitope ID15058) studied as part of Melanoma-associated antigen 2 from Homo sapiens (human), tested in MHC ligand assays

From €105.00*
Details
MAGE-A2 157-166 (HLA-A*02:01) ( YLQLVFGIEV )
YLQLVFGIEV is a linear peptidic epitope (epitope ID74881) studied as part of Melanoma-associated antigen 12 from Homo sapiens (human) and Melanoma-associated antigen 2 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
MAGE-A3 112-120 (HLA-A*02:01) ( KVAELVHFL )
KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated antigen 9 from Homo sapiens (human) and Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity in, tested in T cell assays and MHC ligand assays Antigen Peptide MAGE-A3 112-120 (HLA-A*02:01) KVAELVHFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated antigen 9 from Homo sapiens (human) and Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity in, tested in T cell assays and MHC ligand assays Antigen Peptide MAGE-A3 112-120 (HLA-A*02:01) KVAELVHFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*
Details
MAGE-A3 112-120 mutant (HLA-A*02:01) ( KVAEELVHFL )
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed MAGE-A3 derived peptide of KVAEELVHFL sequence covering 112-120 and A*02:01 molecule.

From €105.00*
Details
MAGE-A3 168-176 (HLA-A*01:01) ( EVDPIGHLY )
EVDPIGHLY is a linear peptidic epitope (epitope ID14672) studied as part of Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
MAGE-A3 271-279 (HLA-A*02:01) ( FLWGPRALV )
FLWGPRALV is a linear peptidic epitope (epitope ID16970) studied as part of Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*
Details
MAGE-A3 97-105 (HLA-A*24:02) ( TFPDLESEF )
#

From €105.00*
Details
MAGE-A4 230–239 (HLA-A*02:01) ( GVYDGREHTV )
GVYDGREHTV is a linear peptidic epitope (epitope ID95091) studied as part of Melanoma-associated antigen 4 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays

From €105.00*
Details
MAGE-C1 1087-1095 (HLA-A*02:01) ( FLAMLKNTV )
#

From €105.00*
Details
MAGE-C2 191-200 (HLA-A*2) ( LLFGLALIEV )
This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed MAGEC2-derived peptide of LLFGLALIEV sequence covering 191-200 and A*02:01 molecule.

From €105.00*
Details
MAGEA-10 254-262 (HLA-A*02:01) ( GLYDGMEHL )
GLYDGMEHL is a linear peptidic epitope (epitope ID189401) studied as part of Melanoma-associated antigen 10 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in MHC ligand assays

From €105.00*
Details
MAGEA1 Peptide Pool, human
Pool of 75 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 1 (MAGEA1) (UniProt ID: P43355) of Homo sapiens (Human) for T cell assays One unit allows the stimulation of 2,5 x 108 cells.

€277.50*
MAGEA10 Peptide Pool, human
Pool of 90 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 10 (MAGEA10) (UniProt ID: P43363) of Homo sapiens (Human) for T cell assays One unit allows the stimulation of 2,5 x 108 cells.

€361.60*
MAGEA11 Peptide Pool, human
Pool of 105 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 11 (MAGEA11) (UniProt ID: P43364) of Homo sapiens (Human) for T cell assays One unit allows the stimulation of 2,5 x 108 cells.

€361.60*
MAGEA3 Peptide Pool, human
Pool of 76 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 3 (MAGEA3) (UniProt ID: P43357) of Homo sapiens (Human) for T cell assays. One unit allows the stimulation of 2,5 x 108 cells.You can find applications and references in our blog post: Esophagogastric adenocarcinoma: Tumor-associated antigens, immune responses and HLA-I Expression

€277.50*
MAGEA4 Peptide Pool, human
Pool of 77 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 4 (MAGEA4) (UniProt ID: P43358) of Homo sapiens (Human) for T cell assays. One unit allows the stimulation of 2,5 x 108 cells.

€277.50*
MAGEA6 Peptide Pool, human
Pool of 76 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma-associated antigen 6 (UniProtKB - P43360) for T cell assays. One unit allows the stimulation of 2,5 x 108 cells. You can find applications and references in our blog post: Esophagogastric adenocarcinoma: Tumor-associated antigens, immune responses and HLA-I Expression

€316.90*
This website uses cookies to ensure the best experience possible. More information...